New eye drug dosing strategy aims to prevent blindness in High-Risk AMD patients
Disease control
Not yet recruiting
This study tests faricimab, an eye injection, using a personalized dosing schedule for people with a specific type of wet age-related macular degeneration (type 3 MNV). The goal is to see if this approach can better preserve vision and prevent disease worsening. About 30 particip…
Phase: PHASE4 • Sponsor: Kim's Eye Hospital • Aim: Disease control
Last updated May 05, 2026 11:56 UTC